Functional vision in daily life: Clinical and patient-reported outcomes 18 months after enhanced partial range of field IOL implantation
Catharina Latz,
Annika Licht,
Katharina A Ponto,
Johannes Menzel-Severing,
David P Piñero and
Alireza Mirshahi
PLOS ONE, 2025, vol. 20, issue 10, 1-11
Abstract:
Background: Partial range of field (PROF) intraocular lenses (IOLs) provide good distance visual acuity with enhanced intermediate visual acuity. Neuroadaptation to new intraocular lenses can take several months. This study investigates visual and patient-reported outcomes (PROMs) in patients implanted with the PROF IOL ICB00 (Johnson & Johnson Vision) 18 months post-surgery. A particular focus was put on spectacle independence while performing activities of daily life. Methods: This ambispective, single-center study included 41 patients (aged 48–84). Visual acuities (distance, intermediate), refraction, and PROMs were assessed ≥18 months post-surgery. Spectacle independence was evaluated using the PRSIQ questionnaire. Patients also self-reported on visual quality, task performance, and photic phenomena. Results: Binocular visual acuity of 0.20 logMAR or better was achieved by 100.0% of patients for uncorrected or corrected distance, by 73.2% for uncorrected intermediate, and by 79.5% for distance-corrected intermediate vision. Photic phenomena were reported by
Date: 2025
References: Add references at CitEc
Citations:
Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0333174 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 33174&type=printable (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0333174
DOI: 10.1371/journal.pone.0333174
Access Statistics for this article
More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().